Kirschner Martin, Heinen Inga Rebecca, Koschmieder Steffen, Manco Licinio, Bento Celeste, Eggermann Thomas, Kurth Ingo, Jost Edgar, Brümmendorf Tim H, Fuchs Roland
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation University Medical Center RWTH Aachen Aachen Germany.
Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) Aachen Germany.
Clin Case Rep. 2022 Mar 4;10(3):e05501. doi: 10.1002/ccr3.5501. eCollection 2022 Mar.
Hereditary pyrimidine 5-nucleotidase (P5'N-1) deficiency is a very rare disorder. Here, we describe a new mutation in a Turkish family. Although functional tests have not been performed, our findings confirm that the homozygous mutational state leads to clinical manifest P5'N-1 deficiency, while heterozygosity does not lead to hemolysis or anemia.
遗传性嘧啶5-核苷酸酶(P5'N-1)缺乏症是一种非常罕见的疾病。在此,我们描述了一个土耳其家庭中的一种新突变。尽管尚未进行功能测试,但我们的研究结果证实,纯合突变状态会导致临床上明显的P5'N-1缺乏症,而杂合子状态不会导致溶血或贫血。